Autoimmune Diseases  >>  bacillus Calmette-Guerin (BCG)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
bacillus Calmette-Guerin (BCG) / Lacocca Family Foundation
NCT00607230: Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics

Completed
1
25
US
BCG, Saline
Massachusetts General Hospital
Type 1 Diabetes Mellitus
12/10
02/11

Download Options